Document ID: chunk:federal_register_of_legislation:F2021C00083:reg:3:p1
Version: federal_register_of_legislation:F2021C00083
Segment Type: reg
Provision Reference: reg 3 (pt 1/2)
Character Range: 5887–8742

3  Definitions
  In this instrument:
Act means the National Health Act 1953.
approved ex‑manufacturer price has the same meaning as in subsection 84(1) of the Act.
approved hospital authority means a hospital authority that has been approved by the Minister under subsection 94(1) of the Act.
Approved Pharmacists Determination means the Commonwealth price (Pharmaceutical benefits supplied by approved pharmacists) Determination 2020 (PB 66 of 2020).
brand has the same meaning as in Part VII of the Act.
current figure has the same meaning as in section 99G of the Act.
dangerous drug means:
 (a) a pharmaceutical benefit mentioned in Schedule 3 to the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019); or
 (b) a pharmaceutical benefit that, under the law of a State or Territory, is classified as a dangerous drug.
dangerous drug fee has the same meaning as in Approved Pharmacists Determination.
determined quantity, of a listed brand of a pharmaceutical item, has the same meaning as in Part VII of the Act.
dispensed price:
 (a) for a ready‑prepared pharmaceutical benefit—has the meaning given by section 9; and
 (b) for an extemporaneously‑prepared pharmaceutical benefit—has the meaning given by subsection 16(1).
extemporaneously‑prepared dispensing fee has the same meaning as in the Approved Pharmacists Determination.
extemporaneously‑prepared pharmaceutical benefit means a pharmaceutical benefit that is not a ready‑prepared pharmaceutical benefit.
listed brand has the same meaning as in Part VII of the Act.
maximum quantity, of a brand of a pharmaceutical item, means a quantity or number of units of the pharmaceutical item determined under paragraph 85A(2)(a) of the Act in relation to that brand of pharmaceutical item.
pack quantity has the same meaning as in subsection 84(1) of the Act.
Note: The Minister may determine one or more pack quantities for a brand of a pharmaceutical item under subsection 84AK(2) of the Act.  The quantities determined are the quantities in manufacturer's PBS packs.
patient co‑payment means:
 (a) for a person to whom, at the time that a pharmaceutical benefit is supplied, paragraph 87(2)(b) of the Act applies—the current figure for the general patient reduced charge, as defined in section 99F of the Act; or
 (b) for a person who is a concessional beneficiary for section 84 of the Act—the current figure for the concessional beneficiary charge, as defined in section 99F of the Act; or
 (c) for any other person—the current figure for the general patient charge, as defined in section 99F of the Act.
pharmaceutical benefit has the meaning given by section 84 of the Act.
pharmaceutical item has the same meaning as in Part VII of the Act.
private hospital means a hospital for which there is